Back to search

Article

Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: An in silico study

2020-06-23

Abstract excerpt

<title>Abstract</title> <p>COVID-19 pandemic has now expanded over 213 nations across the world. To date, there is no specific medication available for SARS CoV-2 infection. The main protease (M<sup>pro</sup>) of SARS CoV-2 plays a crucial role in viral replication and transcription and thereby considered as an attractive drug target for the inhibition of COVID-19,. Natural compounds are widely recognised as valu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3f247874-4fad-5e1b-b6b1-6556c670dcab
DOI
10.21203/rs.3.rs-22839/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: An in silico studyDOI 10.21203/rs.3.rs-22839/v2
Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approachesSemantic proximity
Identification of promising high-affinity inhibitors of SARS-CoV-2 main protease from African Natural Products Databases by Virtual ScreeningSemantic proximity
Nature Potential for COVID-19: Targeting SARS-CoV-2 Mpro Inhibitor with Bioactive CompoundSemantic proximity
In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease InhibitorsSemantic proximity
Small molecules in the treatment of COVID-19Semantic proximity
Evaluation of the inhibitory potential of Bioactive compounds against SARS-CoV2 by in-silico approachSemantic proximity
Phytoconstitutents from Indian medicinal plants show therapeutic potential to combat COVID-19 by bind to SARS CoV-2 Main Protease (Mpro)Semantic proximity
ABBV-744 and Onalespid as Potential Inhibitors of SARS-CoV-2 main Protease Enzyme: A Promising Therapeutics in COVID-19?Semantic proximity
DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity
Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational ApproachesSemantic proximity
Molecular Docking and Clinical Study of Inhibition of Phytochemical Compounds of Nigella Sativa, Matricaria Chamomilla and Origanum Vulgare L on COVID_19 MproSemantic proximity
Discovery of Some Antiviral Natural Products to Fight Against Novel Coronavirus (SARS-CoV-2) Using an In silico ApproachSemantic proximity
Select a neighboring publication to make it the new centre.